A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 202,100 shares of IKNA stock, worth $343,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares
202,100
Previous 173,200 16.69%
Holding current value
$343,570
Previous $285,000 22.46%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.6 - $1.85 $46,240 - $53,465
28,900 Added 16.69%
202,100 $349,000
Q2 2024

Aug 14, 2024

BUY
$1.24 - $1.82 $115,692 - $169,806
93,300 Added 116.77%
173,200 $285,000
Q1 2024

May 15, 2024

BUY
$1.27 - $2.0 $101,473 - $159,800
79,900 New
79,900 $113,000

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $61.6M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.